Department of Respiratory Medicine, Zengcheng people's hospital (Boji-affiliated hospital of Sun Yat-Sen university), Guangzhou 511300, China.
J Ethnopharmacol. 2013 Aug 26;149(1):352-9. doi: 10.1016/j.jep.2013.06.048. Epub 2013 Jul 9.
Danhong injection (DHI), a Chinese Materia Medica standardized product extracted from Radix et Rhizoma Salviae Miltiorrhizae (Salvia miltiorrhiza Bge., Labiatae, Danshen in Chinese) and Flos Carthami (Carthamus tinctorius L., Compositae, Honghua in Chinese), has been reported to have anti-inflammatory, anti-oxidative and anti-fibrinolytic properties, which is used extensively for the treatment of cardiovascular diseases in clinic.
The present study aimed to investigate the preventive and therapeutic effects of DHI on lipopolysaccharide (LPS) induced acute lung injury (ALI) in mice.
Lung injury was induced by intranasal instillation with 10 μg LPS. Mice were randomly divided into four groups: Control group; LPS group; LPS+5 ml/kg DHI group and LPS+10 ml/kg DHI group. The effects of DHI on LPS-induced neutrophils influx, inflammatory cytokines release, protein leakage, myeloperoxidase (MPO) and superoxide dismutase (SOD) activities, malondialdehyde (MDA) level were examined. In addition, the NF-κB activation in lung tissues was detected by Western blot.
In LPS challenged mice, DHI significantly reduced the infiltration of activated neutrophils and decreased the levels of TNF-α and IL-6 in bronchoalveolar lavage fluid (BALF). DHI also inhibited protein extravasation in BALF, attenuated edema and the pathological changes in the lung. In addition, DHI markedly prevented LPS-induced elevation of MDA and MPO levels, as well as reduction of SOD activity. Further study demonstrated that DHI effectively inhibited the NF-κB activation in lung tissues.
DHI has been demonstrated to protect mice from LPS induced acute lung injury by its anti-inflammatory and anti-oxidant activities.
丹红注射液(DHI)是一种从丹参(丹参,唇形科,丹参在中国)和红花(红花,菊科,红花在中国)中提取的中药标准化产品,具有抗炎、抗氧化和抗纤维蛋白溶解作用,临床上广泛用于治疗心血管疾病。
本研究旨在探讨丹红注射液(DHI)对脂多糖(LPS)诱导的急性肺损伤(ALI)小鼠的预防和治疗作用。
肺损伤通过鼻腔内滴注 10 μg LPS 诱导。将小鼠随机分为四组:对照组;LPS 组;LPS+5 ml/kg DHI 组和 LPS+10 ml/kg DHI 组。检测 DHI 对 LPS 诱导的中性粒细胞浸润、炎症细胞因子释放、蛋白渗漏、髓过氧化物酶(MPO)和超氧化物歧化酶(SOD)活性、丙二醛(MDA)水平的影响。此外,通过 Western blot 检测 NF-κB 在肺组织中的激活情况。
在 LPS 挑战的小鼠中,DHI 显著减少了激活的中性粒细胞的浸润,并降低了支气管肺泡灌洗液(BALF)中 TNF-α和 IL-6 的水平。DHI 还抑制了 BALF 中的蛋白外渗,减轻了水肿和肺部的病理变化。此外,DHI 明显防止了 LPS 诱导的 MDA 和 MPO 水平升高以及 SOD 活性降低。进一步的研究表明,DHI 有效地抑制了肺组织中 NF-κB 的激活。
DHI 通过其抗炎和抗氧化作用被证明可以保护小鼠免受 LPS 诱导的急性肺损伤。